Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 10^5 and 10^7 CFU of SC599 Oral Vaccine, a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers

NCT00210288 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.

NCT NCT00210288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 10^5 and 10^7 CFU of SC599 Oral Vaccine, a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers
Lead sponsor
Institut Pasteur
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2005
Completion date
April 30, 2007
Enrollment
111 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

shigella infection